flow semaglutide trial a kidney outcomes trial with once-weekly in people with type 2 diabetes and chronic kidney disease Sema 1.0mg once weekly in CKD+T2D ✓ ↓ Composite kidney events ✓ Slower FLOW trial: In participants with

Liposomes are microscopic spheres made from phospholipidsthe same types of compounds that make up human cell membranes

doi: 10.1016/j.therap.2020.07.008 44 MicallefJ.SoeiroT.Jonville-BraA

Association between left atrial epicardial fat, left atrial volume, and the severity of atrial fibrillation

and Mayo, L.M., "GLP-1 receptor agonists for the treatment of alcohol use disorder," Journal of Clinical Investigation, May 1, 2025, doi: 10.1172/JCI192414 Hendershot, C.S., et al, "Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial," JAMA Psychiatry, April 1, 2025, doi: 10.1001/jamapsychiatry.2024.4789 Wang, W., et al, "Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes : Target Trial Emulation Using Real-World Data," Annals of Internal Medicine, Aug

Academic Press, Elsevier, pp 487506

I take great pride in not only relieving the symptoms you are experiencing, but in correcting the cause of them as well